Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Michigan Supplemental Rebate Program Takes “Best In Class” Approach

Executive Summary

The Michigan Medicaid supplemental rebate program requires manufacturers to match the price of "best-in-class" agents or be subject to prior authorization
Advertisement

Related Content

Michigan Rx List Is More Restrictive Than Private Plans, Kaiser Study Says
Michigan Rx List Is More Restrictive Than Private Plans, Kaiser Study Says
Michigan Rx Rebate Program Upheld In State Court; Federal Suit Pending
Michigan Rx Rebate Program Decision Should Be Left To HHS, DoJ Tells Court
PhRMA Takes Michigan Rebate Dispute To Federal Court Ahead Of Payments
Michigan Supplemental Rx Rebate Program Lacks Statutory Authority – Judge
Florida Medicaid Rx Plan Creates Preferred List, Not Formulary, Court Finds
Michigan Medicaid Rx Program May Spawn Political Backlash, Pfizer Warns
Bristol Glucophage Has Special Status On MI Formulary; Pfizer Offer Fails
PhRMA v. Michigan
Advertisement
UsernamePublicRestriction

Register

PS038902

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel